Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.

Publication ,  Journal Article
Sugino, A; Peebles, CL; Kreuzer, KN; Cozzarelli, NR
Published in: Proc Natl Acad Sci U S A
November 1977

A target protein for nalidixic and oxolinic acids in Escherichia coli, the nalA gene product (Pnal), was purified to homogeneity as judged by gel electrophoresis, using an in vitro complementation assay. It is a dimer of identical 110,000-dalton subunits. A polypeptide of this molecular weight is uniquely induced by a lambda nalA transducing phage, thereby showing that the purified Pnal is a product of the nalA gene. Nalidixic and oxolinic acids inhibit DNA gyrase activity and induce formation of a relaxation complex analogue. Treatment of the complex with sodium dodecyl sulfate causes a doublestrand break in the DNA substrate and the resulting linear molecule seems covalently bound to protein. Complex formation, unlike the introduction of supertwists, does not require ATP or relaxed circular DNA and is insensitive to novobiocin. DNA gyrase from a strain with a nalA mutation conferring drug resistance (nalA(r)) is 1/100 as sensitive to oxolinic and nalidixic acids with respect to inhibition of supertwisting and induction of the pre-linearization complex. Addition of Pnal restores drug sensitivity and stimulates DNA gyrase activity. DNA gyrase preparations and Pnal catalyze a third reaction sensitive to nalidixic and oxolinic acids, the ATP-independent relaxation of supertwister DNA. Relaxation by gyrase from nalA(r) cells is drug resistant. The nicking-closing activity is distinct from E. coli omega protein in several properties, including the ability to relax positively supertwisted DNA. We postulate that the nalA gene product occurs in two molecular forms, as Pnal and as a gyrase component. Both forms catalyze nicking-closing, and inhibition of this activity by nalidixic and oxolinic acids may account for the inhibition of DNA synthesis by these drugs.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Proc Natl Acad Sci U S A

DOI

ISSN

0027-8424

Publication Date

November 1977

Volume

74

Issue

11

Start / End Page

4767 / 4771

Location

United States

Related Subject Headings

  • Transduction, Genetic
  • Protein Biosynthesis
  • Oxolinic Acid
  • Nalidixic Acid
  • Molecular Weight
  • Escherichia coli
  • Enzyme Inhibitors
  • DNA, Superhelical
  • DNA Topoisomerases, Type I
  • DNA Replication
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977). Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A, 74(11), 4767–4771. https://doi.org/10.1073/pnas.74.11.4767
Sugino, A., C. L. Peebles, K. N. Kreuzer, and N. R. Cozzarelli. “Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.Proc Natl Acad Sci U S A 74, no. 11 (November 1977): 4767–71. https://doi.org/10.1073/pnas.74.11.4767.
Sugino, A., et al. “Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.Proc Natl Acad Sci U S A, vol. 74, no. 11, Nov. 1977, pp. 4767–71. Pubmed, doi:10.1073/pnas.74.11.4767.
Journal cover image

Published In

Proc Natl Acad Sci U S A

DOI

ISSN

0027-8424

Publication Date

November 1977

Volume

74

Issue

11

Start / End Page

4767 / 4771

Location

United States

Related Subject Headings

  • Transduction, Genetic
  • Protein Biosynthesis
  • Oxolinic Acid
  • Nalidixic Acid
  • Molecular Weight
  • Escherichia coli
  • Enzyme Inhibitors
  • DNA, Superhelical
  • DNA Topoisomerases, Type I
  • DNA Replication